• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAM9 的结构、调控因子及与癌症相关的生理效应。

Structure, regulatory factors and cancer-related physiological effects of ADAM9.

机构信息

Department of Clinical Medicine, China Medical University , Liaoning, Shenyang, China.

Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University , Liaoning, Shenyang, China.

出版信息

Cell Adh Migr. 2020 Dec;14(1):165-181. doi: 10.1080/19336918.2020.1817251.

DOI:10.1080/19336918.2020.1817251
PMID:32875951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7513870/
Abstract

The ADAMs family belongs to the transmembrane protein superfamily of zinc-dependent metalloproteases, which consists of multiple domains. These domains have independent but complementary functions that enable them to participate in multiple biological processes. Among them, ADAM9 can not only participate in the degradation of extracellular matrix as a metalloprotease, but also mediate tumor cell adhesion through its deintegrin domain, which is closely related to tumor invasion and metastasis. It is widely expressed in a variety of tumor cells and can affect the proliferation, invasion and metastasis of related cancer cells. We provide our views on current progress, its increasing importance as a strategic treatment goal, and our vision for the future of ADAM9.

摘要

ADAMs 家族属于锌依赖型金属蛋白酶跨膜蛋白超家族,由多个结构域组成。这些结构域具有独立但互补的功能,使其能够参与多种生物学过程。其中,ADAM9 不仅可以作为金属蛋白酶参与细胞外基质的降解,还可以通过其解整合素结构域介导肿瘤细胞黏附,与肿瘤的侵袭和转移密切相关。ADAM9 在多种肿瘤细胞中广泛表达,可影响相关癌细胞的增殖、侵袭和转移。我们就 ADAM9 的研究现状、作为一个重要的治疗靶点的意义以及未来展望进行综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/ba2d529a6d61/KCAM_A_1817251_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/fb4bf47d5d29/KCAM_A_1817251_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/1556a8fbb065/KCAM_A_1817251_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/0e5634a0e2e6/KCAM_A_1817251_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/cef6bb1c7906/KCAM_A_1817251_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/ba2d529a6d61/KCAM_A_1817251_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/fb4bf47d5d29/KCAM_A_1817251_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/1556a8fbb065/KCAM_A_1817251_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/0e5634a0e2e6/KCAM_A_1817251_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/cef6bb1c7906/KCAM_A_1817251_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31e8/7513870/ba2d529a6d61/KCAM_A_1817251_F0005_OC.jpg

相似文献

1
Structure, regulatory factors and cancer-related physiological effects of ADAM9.ADAM9 的结构、调控因子及与癌症相关的生理效应。
Cell Adh Migr. 2020 Dec;14(1):165-181. doi: 10.1080/19336918.2020.1817251.
2
An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases.ADAM9 概述:在人类疾病中的结构、激活和调控。
Int J Mol Sci. 2020 Oct 21;21(20):7790. doi: 10.3390/ijms21207790.
3
ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.ADAM9基因沉默可抑制乳腺肿瘤细胞通过血液和淋巴管内皮细胞的迁移。
Biochimie. 2016 Sep-Oct;128-129:174-82. doi: 10.1016/j.biochi.2016.08.006. Epub 2016 Aug 20.
4
ADAM9 silencing inhibits breast tumor cell invasion in vitro.ADAM9 沉默抑制体外乳腺癌细胞侵袭。
Biochimie. 2013 Jul;95(7):1371-8. doi: 10.1016/j.biochi.2013.03.001. Epub 2013 Mar 14.
5
The pleiotropic roles of ADAM9 in the biology of solid tumors.ADAM9 在实体瘤生物学中的多功能作用。
Cell Mol Life Sci. 2018 Jul;75(13):2291-2301. doi: 10.1007/s00018-018-2796-x. Epub 2018 Mar 17.
6
Sorting nexin 9 (SNX9) regulates levels of the transmembrane ADAM9 at the cell surface.分选连接蛋白 9(SNX9)调节细胞表面跨膜 ADAM9 的水平。
J Biol Chem. 2018 May 25;293(21):8077-8088. doi: 10.1074/jbc.RA117.001077. Epub 2018 Apr 5.
7
Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form.氧化应激诱导的肿瘤侵袭依赖于膜 ADAM9 蛋白及其分泌形式。
Int J Cancer. 2011 Aug 15;129(4):791-8. doi: 10.1002/ijc.25746. Epub 2010 Dec 9.
8
ADAMs in cancer cell proliferation and progression.ADAMs在癌细胞增殖和进展中的作用。
Cancer Sci. 2007 May;98(5):621-8. doi: 10.1111/j.1349-7006.2007.00434.x. Epub 2007 Mar 9.
9
microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9.微小 RNA-1298 通过靶向 ADAM9 抑制乳腺癌细胞的恶性行为。
Biosci Rep. 2020 Dec 23;40(12). doi: 10.1042/BSR20201215.
10
MiR-126 regulated breast cancer cell invasion by targeting ADAM9.微小RNA-126通过靶向解聚素金属蛋白酶9调控乳腺癌细胞侵袭。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6547-53. eCollection 2015.

引用本文的文献

1
Anti-metastatic potential of flavonoids for the treatment of cancers: focus on epithelial-mesenchymal transition (EMT) process.黄酮类化合物治疗癌症的抗转移潜力:聚焦于上皮-间质转化(EMT)过程。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 28. doi: 10.1007/s00210-025-04235-3.
2
Potential Influence of Genetic Variants and Expression Levels on the Mutation Status and Disease Progression in Patients with Lung Adenocarcinoma.基因变异和表达水平对肺腺癌患者突变状态及疾病进展的潜在影响
Int J Mol Sci. 2025 May 11;26(10):4606. doi: 10.3390/ijms26104606.
3
Genetic Variants and Their Role in Modulating Enzyme Activity in Diabetes and Metabolic Traits.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Fisetin Induces Apoptosis Through p53-Mediated Up-Regulation of DR5 Expression in Human Renal Carcinoma Caki Cells.漆黄素通过p53介导的人肾癌Caki细胞中DR5表达上调诱导细胞凋亡。
Molecules. 2017 Aug 2;22(8):1285. doi: 10.3390/molecules22081285.
3
miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer.
基因变异及其在调节糖尿病和代谢性状中酶活性的作用。
J Diabetes Res. 2025 Apr 28;2025:5519447. doi: 10.1155/jdr/5519447. eCollection 2025.
4
ADAM9 mediates Cisplatin resistance in gastric cancer cells through DNA damage response pathway.ADAM9通过DNA损伤反应途径介导胃癌细胞对顺铂的耐药性。
Med Oncol. 2025 Mar 20;42(4):122. doi: 10.1007/s12032-025-02645-0.
5
Genetic variants of ADAM9 as potential predictors for biochemical recurrence in prostate cancer patients after receiving a radical prostatectomy.ADAM9基因变异作为前列腺癌患者接受根治性前列腺切除术后生化复发的潜在预测指标。
Int J Med Sci. 2024 Nov 4;21(15):2934-2942. doi: 10.7150/ijms.103179. eCollection 2024.
6
Revealing the mechanisms of RAC3 in tumor aggressiveness, the immunotherapy response, and drug resistance in bladder cancer.揭示RAC3在膀胱癌肿瘤侵袭性、免疫治疗反应和耐药性中的机制。
Front Oncol. 2024 Sep 16;14:1466319. doi: 10.3389/fonc.2024.1466319. eCollection 2024.
7
An Antibody of the Secreted Isoform of Disintegrin and Metalloprotease 9 (sADAM9) Inhibits Epithelial-Mesenchymal Transition and Migration of Prostate Cancer Cell Lines.一种分泌型解整合素金属蛋白酶 9(sADAM9)的抗体抑制前列腺癌细胞系的上皮-间质转化和迁移。
Int J Mol Sci. 2024 Jun 17;25(12):6646. doi: 10.3390/ijms25126646.
8
MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications.癌症中微小RNA与受体的蛋白水解切割:调控相互作用及治疗意义的全面综述
Heliyon. 2024 Mar 20;10(7):e28167. doi: 10.1016/j.heliyon.2024.e28167. eCollection 2024 Apr 15.
9
The dual role of microRNA (miR)-20b in cancers: Friend or foe?微小 RNA(miR)-20b 在癌症中的双重作用:是敌是友?
Cell Commun Signal. 2023 Jan 30;21(1):26. doi: 10.1186/s12964-022-01019-7.
10
Trends in accessibility of negotiated targeted anti-cancer medicines in Nanjing, China: An interrupted time series analysis.中国南京谈判靶向抗癌药物可及性的变化趋势:一项中断时间序列分析。
Front Public Health. 2022 Jul 22;10:942638. doi: 10.3389/fpubh.2022.942638. eCollection 2022.
微小RNA-20b通过抑制结肠癌中的ADAM9/表皮生长因子受体信号通路降低5-氟尿嘧啶耐药性。
Oncol Rep. 2017 Jan;37(1):123-130. doi: 10.3892/or.2016.5259. Epub 2016 Nov 18.
4
MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1.微小RNA-33a通过靶向解聚素和金属蛋白酶9(ADAM9)及ROS1抑制乳腺癌细胞的增殖和转移。
Protein Cell. 2015 Dec;6(12):881-9. doi: 10.1007/s13238-015-0223-8. Epub 2015 Oct 27.
5
MiR-126 regulated breast cancer cell invasion by targeting ADAM9.微小RNA-126通过靶向解聚素金属蛋白酶9调控乳腺癌细胞侵袭。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6547-53. eCollection 2015.
6
RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.RNA干扰介导的解整合素金属蛋白酶9基因沉默在体外和体内均可抑制非小细胞肺癌的肿瘤生长。
Mol Med Rep. 2015 Jul;12(1):1197-204. doi: 10.3892/mmr.2015.3477. Epub 2015 Mar 12.
7
ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.ADAM-9是腱生蛋白-C刺激脑肿瘤起始细胞侵袭的一种新型介质。
Neuro Oncol. 2015 Aug;17(8):1095-105. doi: 10.1093/neuonc/nou362. Epub 2015 Feb 1.
8
Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma.miR-126 低表达是转移性透明细胞肾细胞癌的预后标志物。
Am J Pathol. 2015 Mar;185(3):693-703. doi: 10.1016/j.ajpath.2014.11.017. Epub 2015 Jan 5.
9
Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.微小RNA-126表达降低与宫颈癌患者的不良预后相关。
Diagn Pathol. 2014 Dec 31;9:220. doi: 10.1186/s13000-014-0220-x.
10
Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2.漆黄素通过增加细胞外信号调节激酶1/2(ERK1/2)的磷酸化来抑制解聚素和金属蛋白酶9(ADAM9)的表达并抑制胶质瘤癌细胞的侵袭。
Tumour Biol. 2015 May;36(5):3407-15. doi: 10.1007/s13277-014-2975-9. Epub 2014 Dec 20.